Summary

Introduction to Europe Digital PCR Market

The Europe digital PCR (d-PCR) market is projected to reach $762.7 million by 2034 from $183.9 million in 2024, growing at a CAGR of 15.29% during the forecast period 2024-2034. The market for digital PCRs in Europe has grown by double digits due to the increasing use of personalised medicine for genetic disorder screening and diagnosis. This patient-specific strategy relies heavily on digital PCR (dPCR), which accurately identifies and measures uncommon genetic mutations connected to a range of cancers. Furthermore, the need for quick and precise diagnostic solutions is being fuelled by the growing incidence of infectious diseases throughout Europe. The market's growth in Europe is being greatly aided by technological advancements like droplet digital PCR, nanoplate technology, and microfluidic platforms, which are improving dPCR capabilities.

Market Introduction

The market for digital PCR is growing quickly in Europe due to the growing use of personalised medicine and the need for extremely accurate diagnostics. With its remarkable sensitivity and specificity, digital PCR (dPCR) is especially useful for identifying low-abundance genetic mutations and measuring biomarkers that are essential for early diagnosis and treatment monitoring. Increasing rates of infectious diseases, genetic disorders, and cancers have prompted investments in cutting-edge molecular diagnostic technologies.

The accuracy, throughput, and ease of integration of assays into clinical workflows have been greatly enhanced by technological advancements like droplet digital PCR, nanoplate technology, and microfluidic platforms. Furthermore, market adoption has accelerated throughout the continent due to government initiatives, favourable regulatory frameworks, and increased funding for healthcare infrastructure. The European digital PCR market is expected to grow steadily as top research institutes and business leaders keep working together to create reliable, patient-specific diagnostic solutions. In addition to changing the molecular diagnostics landscape, this dynamic market is opening the door for individualised treatment plans that improve patient outcomes.

Overall, the convergence of technological innovation, regulatory support, and evolving clinical demands is driving the digital PCR market's robust expansion in Europe. Additionally, growing research collaborations and investments will further integrate digital PCR in Europe.

Market Segmentation:

Segmentation 1: by Application
• Clinical and Research Application
• Environmental Application
• Other Application

Segmentation 2: by End User
• Academic and Research Institutes
• Hospitals and Clinics
• Diagnostic Centers
• Pharmaceutical and Biopharmaceutical Companies
• Other End User

Segmentation 3: by Region
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe digital PCR market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Mergers, acquisitions, and product launches accounted for the maximum number of key developments.

Competitive Strategy: The Europe digital PCR market has numerous established players with product portfolios. Key players in the Europe digital PCR market analyzed and profiled in the study involve established players offering products for digital PCR.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• QIAGEN N.V.
• F. Hoffmann-La Roche Ltd
• Merck KGaA
• Stilla Technologies Inc.
• SAGA Diagnostics AB
• JETA Molecular BV.

ページTOPに戻る

Table of Contents

Executive Summary
Scope and Definition
1 Markets
1.1 Market Overview
1.1.1 Workflow of Digital PCR
1.1.2 Comparison of qPCR and dPCR
1.2 Trends: Current and Future Impact Assessment
1.2.1 Integration with Next-Generation Sequencing (NGS)
1.2.2 Increased Real-time Monitoring and Point-of-care Applications of Digital PCR
1.2.3 Increasing Product Launches in d-PCR Ecosystem
1.3 Supply Chain Overview
1.4 Research and Development Review
1.4.1 Patent Filing Trend (by Region)
1.4.2 Patent Filing Trend (by Country)
1.4.3 Patent Filing Trend (by Year)
1.5 Ongoing Digital PCR Clinical Trials
1.6 Regulatory Landscape
1.6.1 European Union
1.7 Market Dynamics Overview
1.7.1 Market Drivers
1.7.1.1 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
1.7.1.2 Increasing Incidence of Infectious Diseases
1.7.1.3 Technological Advancement in dPCR to Enhance Market Growth
1.7.2 Market Restraints
1.7.2.1 High Cost of Platforms Associated with Digital-PCR
1.7.2.2 Shortage of Skilled Professionals and Trained Laboratory Technicians
1.7.3 Market Opportunities
1.7.3.1 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
1.7.3.2 Growing Adoption of dPCR in Emerging Markets
2 Regions
2.1 Regional Summary
2.2 Drivers and Restraints
2.3 Europe
2.3.1 Regional Overview
2.3.2 Driving Factors for Market Growth
2.3.3 Factors Challenging the Market
2.3.4 By Application
2.3.5 By End User
2.3.6 France
2.3.7 Germany
2.3.8 U.K.
2.3.9 Spain
2.3.10 Italy
2.3.11 Rest-of-Europe
3 Markets - Competitive Benchmarking & Company Profiles
3.1 Competitive Landscape
3.1.1 Mergers and Acquisitions
3.1.2 Synergistic Activities
3.1.3 Product Launch and Approval Activities
3.1.4 Expansion, Funding, and Other Activities
3.2 Market Share Analysis
3.3 Company Profile
3.3.1 QIAGEN N.V.
3.3.1.1 Overview
3.3.1.2 Top Products/Product Portfolio
3.3.1.3 Top Competitors
3.3.1.4 Target Customers
3.3.1.5 Key Personnel
3.3.1.6 Analyst View
3.3.2 F. Hoffmann-La Roche Ltd
3.3.2.1 Overview
3.3.2.2 Top Products/Product Portfolio
3.3.2.3 Top Competitors
3.3.2.4 Target Customers
3.3.2.5 Key Personnel
3.3.2.6 Analyst View
3.3.3 Merck KGaA
3.3.3.1 Overview
3.3.3.2 Top Products/Product Portfolio
3.3.3.3 Top Competitors
3.3.3.4 Target Customers
3.3.3.5 Key Personnel
3.3.3.6 Analyst View
3.3.4 Stilla Technologies Inc.
3.3.4.1 Overview
3.3.4.2 Top Products/Product Portfolio
3.3.4.3 Top Competitors
3.3.4.4 Target Customers
3.3.4.5 Key Personnel
3.3.4.6 Analyst View
3.3.5 SAGA Diagnostics AB
3.3.5.1 Overview
3.3.5.2 Top Products/Product Portfolio
3.3.5.3 Top Competitors
3.3.5.4 Target Customers
3.3.5.5 Key Personnel
3.3.5.6 Analyst View
3.3.6 JETA Molecular BV.
3.3.6.1 Overview
3.3.6.2 Top Products/Product Portfolio
3.3.6.3 Top Competitors
3.3.6.4 Target Customers
3.3.6.5 Key Personnel
3.3.6.6 Analyst View
4 Research Methodology
4.1 Data Sources
4.1.1 Primary Data Sources
4.1.2 Secondary Data Sources
4.1.3 Data Triangulation
4.2 Market Estimation and Forecast

ページTOPに戻る

List of Tables/Graphs

List of Figures
Figure 1: Digital PCR Market, by Region, $Million, 2023, 2029, and 2034
Figure 2: Europe Digital PCR Market (by Application), $Million 202, 2029 and 2034
Figure 3: Europe Digital PCR Market (by End User), $Million, 2023, 2029, and 2034
Figure 4: Key Events to Keep Track of in the Digital PCR Market
Figure 5: Supply Chain and Risks within the Supply Chain
Figure 6: Digital PCR Market (by Region), January 2020-September 2024
Figure 7: Digital PCR Market (by Country), January 2020-September 2024
Figure 8: Digital PCR Market (by Year), January 2020-September 2024
Figure 9: Impact Analysis of Market Navigating Factors, 2024-2034
Figure 10: France Digital PCR Market, $Million, 2023-2034
Figure 11: Germany Digital PCR Market, $Million, 2023-2034
Figure 12: U.K. Digital PCR Market, $Million, 2023-2034
Figure 13: Spain Digital PCR Market, $Million, 2023-2034
Figure 14: Italy Digital PCR Market, $Million, 2023-2034
Figure 15: Rest-of-Europe Digital PCR Market, $Million, 2023-2034
Figure 16: Strategic Initiatives, January 2019-September 2024
Figure 17: Share of Strategic Initiatives, January 2019-September 2024
Figure 18: Digital PCR Market, Mergers and Acquisitions, January 2019-September 2024
Figure 19: Digital PCR Market, Synergistic Activities, January 2019-September 2024
Figure 20: Digital PCR Market, Product Launch and Approval Activities, January 2019-September 2024
Figure 21: Digital PCR Market, Expansion, Funding, and Other Activities January 2019-September 2024
Figure 22: Data Triangulation
Figure 23: Bottom-Up Approach (Segment-Wise Analysis)
Figure 24: Top-Down Approach (Segment-Wise Analysis)
Figure 25: Assumptions and Limitations
List of Tables
Table 1: Market Snapshot
Table 2: Opportunities across Regions
Table 3: Digital PCR Market, Share Analysis, 2023
Table 4: Comparison of qPCR and dPCR
Table 5: Digital PCR Market, Trend Analysis
Table 6: Digital PCR Market, Recent Product Launches
Table 7: Some of the Ongoing Digital PCR (d-PCR) Clinical Trials
Table 8: Funding Allocated for Precision Medicine to Different Agencies Globally
Table 9: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
Table 10: Digital PCR Market (by Region), $Million, 2023-2034
Table 11: Europe Digital PCR Market (by Application), $Million, 2023-2034
Table 12: Europe Digital PCR Market (by End User), $Million, 2023-2034
Table 13: France Digital PCR Market (by Application), $Million, 2023-2034
Table 14: France Digital PCR Market (by End User), $Million, 2023-2034
Table 15: Germany Digital PCR Market (by Application), $Million, 2023-2034
Table 16: Germany Digital PCR Market (by End User), $Million, 2023-2034
Table 17: U.K. Digital PCR Market (by Application), $Million, 2023-2034
Table 18: U.K. Digital PCR Market (by End User), $Million, 2023-2034
Table 19: Spain Digital PCR Market (by Application), $Million, 2023-2034
Table 20: Spain Digital PCR Market (by End User), $Million, 2023-2034
Table 21: Italy Digital PCR Market (by Application), $Million, 2023-2034
Table 22: Italy Digital PCR Market (by End User), $Million, 2023-2034
Table 23: Rest-of-Europe Digital PCR Market (by Application), $Million, 2023-2034
Table 24: Rest-of-Europe Digital PCR Market (by End User), $Million, 2023-2034
Table 25: Digital PCR Market. Market Share Analysis, 2023